We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Needs Independent Ethics Board To Assess Postmarket Studies
FDA Needs Independent Ethics Board To Assess Postmarket Studies
August 29, 2012
An independent ethics advisory board could help the FDA assess the risks and benefits of approved drugs and firm up its decisionmaking on required postmarket trials, according to a new report that advocates creating such a group.